Antibody to amyloid beta protein alleviates impaired acquisition, retention, and memory processing in SAMP8 mice
- PMID: 12071671
- DOI: 10.1006/nlme.2001.4047
Antibody to amyloid beta protein alleviates impaired acquisition, retention, and memory processing in SAMP8 mice
Abstract
SAMP8 (senescence-accelerated mouse, P8 strain) mice overproduce amyloid precursor protein and beta-amyloid and have learning and memory deficits. Preliminary data have indicated that overproduction of beta-amyloid plays a role in the pathogenesis of acquisition and retention deficits in SAMP8 mice. In the studies reported here, the authors examined the effects of polyclonal and monoclonal antibodies to beta-amyloid on acquisition and retention in an aversive T-maze testing paradigm when injected intracerebroventricularly (ICV) into 12-month SAMP8/TaJF mice. Both the polyclonal and monoclonal antibodies improved acquisition and retention when injected ICV 1 to 14 days prior to acquisition testing. Injection of all three antibodies intrahippocampally immediately following training improved retention on the T-maze when mice were tested 7 days later. The authors next studied the effect of monoclonal beta-amyloid antibody injected 48 h prior to training on the effect on retention in the T-maze of drugs modulating classical neurotransmitters. Arecoline and glutamate were injected directly into the hippocampus, and ketanserin, methiothepen, bicuculline, and OH-saclofen were injected into the septum. Previously, the authors have found that the doses of these drugs required to improve retention are markedly altered in 12-month SAMP8/TkJF mice compared to 4-month P8 mice. In these studies, it was demonstrated that antibody to beta-amyloid resulted in these drugs improving retention at doses that improved memory in 4-month SAMP8/TaJF mice. Based on these findings, we conclude that beta-amyloid overproduction is at least in part responsible for the acquisition and memory deficits in 12-month-old SAMP8/TaJF mice. Antibody to beta-amyloid restores the retention response to neurotransmitter manipulation to that seen in 4-month-old mice. beta-amyloid appears to play a key role in the loss of acquisition and retention seen in SAMP8/TaJF mice.
Copyright 2002 Elsevier Science (USA).
Similar articles
-
Effects of leptin on memory processing.Peptides. 2006 Jun;27(6):1420-5. doi: 10.1016/j.peptides.2005.10.006. Epub 2005 Nov 15. Peptides. 2006. PMID: 16293343
-
DHEAS improves learning and memory in aged SAMP8 mice but not in diabetic mice.Life Sci. 2004 Oct 22;75(23):2775-85. doi: 10.1016/j.lfs.2004.05.026. Life Sci. 2004. PMID: 15464829
-
Administration of amyloid-β42 oligomer-specific monoclonal antibody improved memory performance in SAMP8 mice.J Alzheimers Dis. 2011;23(3):551-61. doi: 10.3233/JAD-2010-091195. J Alzheimers Dis. 2011. PMID: 21297277
-
Calcium channel antagonists enhance retention of passive avoidance and maze learning in mice.Neurobiol Learn Mem. 2001 Jan;75(1):77-90. doi: 10.1006/nlme.1999.3958. Neurobiol Learn Mem. 2001. PMID: 11124048
-
Learning and memory in the SAMP8 mouse.Neurosci Biobehav Rev. 1998;22(1):1-20. doi: 10.1016/s0149-7634(96)00063-2. Neurosci Biobehav Rev. 1998. PMID: 9491937 Review.
Cited by
-
Amyloid and tau pathology of familial Alzheimer's disease APP/PS1 mouse model in a senescence phenotype background (SAMP8).Age (Dordr). 2015 Feb;37(1):9747. doi: 10.1007/s11357-015-9747-3. Epub 2015 Feb 8. Age (Dordr). 2015. PMID: 25663420 Free PMC article.
-
Dietary resveratrol prevents Alzheimer's markers and increases life span in SAMP8.Age (Dordr). 2013 Oct;35(5):1851-65. doi: 10.1007/s11357-012-9489-4. Epub 2012 Nov 7. Age (Dordr). 2013. PMID: 23129026 Free PMC article.
-
Intranasal administration of PACAP: uptake by brain and regional brain targeting with cyclodextrins.Peptides. 2012 Aug;36(2):168-75. doi: 10.1016/j.peptides.2012.05.021. Epub 2012 Jun 9. Peptides. 2012. PMID: 22687366 Free PMC article.
-
Long-Term Treatment with Liraglutide, a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, Has No Effect on β-Amyloid Plaque Load in Two Transgenic APP/PS1 Mouse Models of Alzheimer's Disease.PLoS One. 2016 Jul 15;11(7):e0158205. doi: 10.1371/journal.pone.0158205. eCollection 2016. PLoS One. 2016. PMID: 27421117 Free PMC article.
-
The GLP-1 Receptor Agonist Liraglutide Improves Memory Function and Increases Hippocampal CA1 Neuronal Numbers in a Senescence-Accelerated Mouse Model of Alzheimer's Disease.J Alzheimers Dis. 2015;46(4):877-88. doi: 10.3233/JAD-143090. J Alzheimers Dis. 2015. PMID: 25869785 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical